Table 3.
Pre- to post-treatment (n = 178) | F (df) = | p |
---|---|---|
Age | F (1,170) = 0.12 | .78 |
Gender | F (1,170) = 2.74 | .10 |
Race | F (1,170) = 0.22 | .64 |
Treatment condition | F (2,170) = 2.56 | .08 |
k value | F (1,170) = 0.32 | .57 |
h value | F (1,170) = 3.92 | .04 |
Throughout 12-month follow-up (n = 153) | ||
Age | F (2,290) = 0.21 | .81 |
Gender | F (2,290) = 0.95 | .39 |
Race | F (2,290) = 0.39 | .68 |
Treatment condition | F (4,290) = 1.43 | .23 |
k value | F (2,290) = 0.49 | .61 |
h value | F (2,290) = 1.58 | .20 |